COVID-19 is a rapidly evolving situation. When working in different community settings, follow CDC guidance to help prevent the spread of COVID-19. Visit www.cdc.gov/coronavirus for the latest public health information.
Multicomponent Interventions to Increase Cancer Screening are Cost-Effective
A new systematic review of economic evidence shows multicomponent interventions to increase screenings for cervical or colorectal cancer are cost-effective. There was not enough information to determine cost-effectiveness for interventions aimed at increasing breast cancer screening.
The review included evidence from 54 studies published through January 2018. Studies evaluated multicomponent interventions to increase screenings for breast (14 studies), cervical (6 studies), and colorectal (34 studies) cancers.
For More Information:
- The Community Guide: Cancer
- Cancer Screening: Multicomponent Interventions – Breast Cancer
- Cancer Screening: Multicomponent Interventions – Cervical Cancer
- Cancer Screening: Multicomponent Interventions – Colorectal Cancer
- Community Guide in Action: New York: Increasing Cancer Screenings, Saving Lives
- One Pagers
- Division of Cancer Prevention and Control, CDC - official account for the Community Preventive Services Task Force